Early Experience Using Intravesical Gene Therapy for NMIBC:

For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.

Related Keywords

United States , Arizona , Banner Gateway Medical Center , American , Chinedu Mmeje , Joseph Mashni Jr , Urol Onc , American Cancer Society , National Cancer Institute , Banner Md Anderson Cancer Center , Early Experience Program , Bacillus Calmette Guerin , Gene Therapy , New Option , Ferring Pharmaceutical , Cancer Center , Clinical Experience , Intravesical Gene , Early Experience , Accessed February , National Cancer , Updated February , Eur Urol ,